fda warning bpc 157 peptide products New Details 157 When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian